H.R. 5414: FDA Cross-Center Collaboration Act of 2016

To amend the Federal Food, Drug, and Cosmetic Act to provide for establishment of one or more Intercenter Institutes within the Food and Drug Administration for a major disease area or areas, and for other purposes.

The bill’s titles are written by its sponsor.

What you can do



Jun 8, 2016


Referred to Committee on Jun 8, 2016

This bill was assigned to a congressional committee on June 8, 2016, which will consider it before possibly sending it on to the House or Senate as a whole.


Fred Upton

Representative for Michigan's 6th congressional district



Read Text »
Last Updated: Jun 8, 2016
Length: 4 pages


Jun 8, 2016

This is the first step in the legislative process.

Reported by Committee

Passed House

Passed Senate

Signed by the President

H.R. 5414 is a bill in the United States Congress.

A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.

How to cite this information.

We recommend the following MLA-formatted citation when using the information you see here in academic work:

“H.R. 5414 — 114th Congress: FDA Cross-Center Collaboration Act of 2016.” www.GovTrack.us. 2016. October 22, 2016 <https://www.govtrack.us/congress/bills/114/hr5414>

Where is this information from?

GovTrack automatically collects legislative information from a variety of governmental and non-governmental sources. This page is sourced primarily from Congress.gov, the official portal of the United States Congress. Congress.gov is generally updated one day after events occur, and so legislative activity shown here may be one day behind. Data via the congress project.